How our health will change in the next 5 years thanks to the innovation of personalized treatments, after the impact of the pandemic.
And then again what are the critical issues that we will have to face in the coming years and what, instead, the progress of innovation and research that will change the approach to the diagnosis and treatment of the main pathologies, from infections, including antibiotic resistant ones, to tumors .
These are the themes of an ANSA Incontra that will be broadcast on Tuesday 15 November on ANSA.it at 12.
or
In this scenario there is also a chapter on the role of pharma companies, which produce and support innovation.
The study will be carried out with the contribution of some guests: Valentina Marino, Medical Director of Pfizer Italy;
Cesare Gridelli, Director of the Onco-Hematology Department, SG Moscati Hospital of Avellino, Past-President AIOT - Italian Association of Thoracic Oncology and Pierluigi Viale, Director of the Infectious Diseases Unit, AOU Policlinico S.
Orsola Malpighi of Bologna.
In collaboration with:
Pfizer
